QT
CANO

Quantbot Technologies’s Cano Health, Inc. CANO Stock Holding History

Quantbot Technologies’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,714
Closed -$235K – 2195
2022
Q4 		$235K Buy
+1,714
New +$580K 0.02% 841

Other funds holding CANO

DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Quantbot Technologies's CANO Position: Q1 2023 in Review

Quantbot Technologies sold out of Cano Health, Inc. (CANO) in Q1 2023, closing a stake of 1,714 shares — an estimated $235K sold.

Quantbot Technologies first reported a position in CANO in Q4 2022 and held it in 1 quarter. The position peaked at $235K in Q4 2022. 163 funds tracked by Wall St. Rank hold CANO as of Q1 2023.

  • Quantbot Technologies reported no remaining Cano Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 1,714 Cano Health, Inc. shares in Q1 2023, an estimated $235K.
  • Quantbot Technologies first reported a position in Cano Health, Inc. in Q4 2022 and held it in 1 quarter.
  • Quantbot Technologies's Cano Health, Inc. position peaked at $235K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.